[ARS] Celularity Inc SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

ARS

11/07/2025 - 01:19 PM

ARS - Celularity Inc

ARS Filing - Celularity Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: Celularity Inc (CELU)

Acceptance Date: 2025-11-07T13:19:07.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Celularity Inc

NASDAQ:CELU

View CELU Stock Overview →

CELU Rankings

#5791 Ranked by Market Cap

N/A Ranked by Dividends

CELU Latest News

Mar 12, 2026

Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities

Mar 10, 2026

Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy

Feb 10, 2026

Celularity Receives $12.2 Million from Sale of New Jersey Net Operating Losses

Dec 26, 2025

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

Dec 22, 2025

Celularity Announces Closing of Financing Transactions

CELU Latest SEC Filings

Mar 10, 2026

[8-K] Celularity Inc Reports Material Event

Mar 5, 2026

[8-K] Celularity Inc Reports Material Event

Feb 11, 2026

[SCHEDULE 13G/A] Celularity Inc Amended Passive Investment Disclosure

Jan 21, 2026

[8-K] Celularity Inc Reports Material Event

Jan 14, 2026

[Form 4] Celularity Inc Insider Trading Activity

CELU Stock Data

Market Cap 38.35M

Float 18.05M

Industry Biotechnology

Sector Pharmaceutical Preparations

Website Link

Country United States

City FLORHAM PARK